CIK 0001453687
- Non-accelerated filer
- Smaller reporting company
Cartesian Therapeutics, Inc.
Sign in to watch- Ticker
- RNAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-348-8698
- Business address
- 7495 NEW HORIZON WAY, FREDERICK, MD, 21703
- Former names
- SELECTA BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-06 | Kurtoglu Metin Chief Technology Officer | Sale | −2,458 | $16.83 | $41K | 62,258 |
| 2025-01-03 | Kurtoglu Metin Chief Technology Officer | Sale | −2,417 | $16.72 | $40K | 64,716 |
| 2025-01-02 | Kurtoglu Metin Chief Technology Officer | Grant or award | +16,100 | 67,133 | ||
| 2025-01-02 | Kurtoglu Metin Chief Technology Officer | Grant or award · Employee Stock Option (right to buy) | +47,400 | 47,400 | ||
| 2024-12-10 | Kurtoglu Metin Chief Technology Officer | Exercise or conversion | +2,901 | $1.41 | $4K | 53,934 |
| 2024-12-10 | Kurtoglu Metin Chief Technology Officer | Sale | −2,901 | $24.35 | $71K | 51,033 |
| 2024-12-10 | Kurtoglu Metin Chief Technology Officer | Exercise or conversion · Stock Option (Right to Buy) | −2,901 | 79,099 | ||
| 2024-12-09 | Kurtoglu Metin Chief Technology Officer | Exercise or conversion | +10,763 | $1.41 | $15K | 61,796 |
| 2024-12-09 | Kurtoglu Metin Chief Technology Officer | Sale | −6,224 | $25.26 | $157K | 55,572 |
| 2024-12-09 | Kurtoglu Metin Chief Technology Officer | Sale | −4,539 | $25.83 | $117K | 51,033 |
| 2024-12-09 | Kurtoglu Metin Chief Technology Officer | Exercise or conversion · Stock Option (Right to Buy) | −10,763 | 82,000 | ||
| 2024-11-21 | Kurtoglu Metin Chief Technology Officer | Exercise or conversion | +32,789 | $1.41 | $46K | 83,822 |
| 2024-11-21 | Kurtoglu Metin Chief Technology Officer | Sale | −32,789 | $16.67 | $547K | 51,033 |
| 2024-11-21 | Kurtoglu Metin Chief Technology Officer | Exercise or conversion · Stock Option (Right to Buy) | −32,789 | 92,763 | ||
| 2024-11-20 | Kurtoglu Metin Chief Technology Officer | Exercise or conversion | +5,700 | $1.41 | $8K | 56,733 |
| 2024-11-20 | Kurtoglu Metin Chief Technology Officer | Sale | −5,600 | $17.28 | $97K | 51,133 |
| 2024-11-20 | Kurtoglu Metin Chief Technology Officer | Sale | −100 | $18.09 | $2K | 51,033 |
| 2024-11-20 | Kurtoglu Metin Chief Technology Officer | Exercise or conversion · Stock Option (Right to Buy) | −5,700 | 125,552 | ||
| 2024-11-19 | Kurtoglu Metin Chief Technology Officer | Exercise or conversion | +200 | $1.41 | $282 | 51,233 |
| 2024-11-19 | Kurtoglu Metin Chief Technology Officer | Sale | −200 | $19.50 | $4K | 51,033 |
Page 1 of 3 · 43 trades